ARTICLE
13 September 2016

Pharmaceutical Trademark Guide 2017/2018 – A Global Guide – Canada Chapter

BP
Bereskin & Parr LLP
Contributor
Bereskin & Parr LLP is a leading Canadian full service intellectual property law firm serving clients across all industries around the world. The firm services clients in every aspect of patent, trademark and copyright law, IP litigation and Regulatory, Advertising & Marketing.
Various legislative and regulatory changes are expected to bring both benefits and challenges to applicants in all industries by 2018.
Canada Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Publication: World Trademark Review

Susan Keri, Jennifer McKenzie and Meghan Dillon discuss upcoming developments affecting pharmaceutical trademarks in Canada. Various legislative and regulatory changes are expected to bring both benefits and challenges to applicants in all industries by 2018.

This article first appeared in Pharmaceutical Trademarks: A Global Guide 2017/2018, a supplement to World Trademark Review, published by Globe Business Media Group - IP Division.

To view the guide in full, please go to http://www.worldtrademarkreview.com.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
13 September 2016

Pharmaceutical Trademark Guide 2017/2018 – A Global Guide – Canada Chapter

Canada Intellectual Property
Contributor
Bereskin & Parr LLP is a leading Canadian full service intellectual property law firm serving clients across all industries around the world. The firm services clients in every aspect of patent, trademark and copyright law, IP litigation and Regulatory, Advertising & Marketing.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More